Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015

Details for Mechanism ID: 12130
Country/Region: Malawi
Year: 2015
Main Partner: Baylor College of Medicine
Main Partner Program: Children's Foundation
Organizational Type: University
Funding Agency: USAID
Total Funding: $6,013,481 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $106,065
Care: TB/HIV (HVTB) $219,112
Care: Pediatric Care and Support (PDCS) $600,000
Laboratory Infrastructure (HLAB) $100,000
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $200,000
Testing: HIV Testing and Counseling (HVCT) $918,533
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $179,408
Treatment: Adult Treatment (HTXS) $1,036,564
Treatment: Pediatric Treatment (PDTX) $2,653,799
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 29,592
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 7,915
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 140,859
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 140,788
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 375,636
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 350,138
HTS_TST By Test Result: Negative 2016 940,085
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 1,007,421
HTS_TST Sum of Aggregated Age/Sex <15 2016 281,647
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 725,774
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 1,007,421
HTS_TST Sum of Test Result disaggregates 2016 1,007,421
HTS_TST_POS By Test Result: Positive 2016 67,336
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 728
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 692
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 360
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 332
PMTCT_ARV Sum of New and Current disaggregates 2016 692
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 584
PMTCT_STAT By: Known positives at entry 2016 327
PMTCT_STAT By: Number of new positives identified 2016 401
PMTCT_STAT Number of new ANC and L&D clients 2016 12,820
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 12,179
PMTCT_STAT Sum of Positives Status disaggregates 2016 728
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 29,592
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 28,881
TX_CURR Age/Sex: <1 Female 2016 256
TX_CURR Age/Sex: <1 Male 2016 216
TX_CURR Age/Sex: 1-4 Female 2016 2,010
TX_CURR Age/Sex: 1-4 Male 2016 1,865
TX_CURR Age/Sex: 5-14 Female 2016 9,427
TX_CURR Age/Sex: 5-14 Male 2016 9,483
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 33,689
TX_CURR Sum of age/sex disaggregates 2016 33,689
TX_NEW Breastfeeding status 2016 171
TX_NEW By Age/Sex: <1 Female 2016 518
TX_NEW By Age/Sex: <1 Male 2016 485
TX_NEW By Age/Sex: 1-4 Female 2016 1,009
TX_NEW By Age/Sex: 1-4 Male 2016 1,107
TX_NEW By Age/Sex: 10-14 Female 2016 801
TX_NEW By Age/Sex: 10-14 Male 2016 690
TX_NEW By Age/Sex: 15-19 Female 2016 70
TX_NEW By Age/Sex: 15-19 Male 2016 20
TX_NEW By Age/Sex: 20-24 Female 2016 266
TX_NEW By Age/Sex: 20-24 Male 2016 32
TX_NEW By Age/Sex: 25-49 Female 2016 1,243
TX_NEW By Age/Sex: 25-49 Male 2016 724
TX_NEW By Age/Sex: 5-9 Female 2016 780
TX_NEW By Age/Sex: 5-9 Male 2016 904
TX_NEW By Age/Sex: 50+ Female 2016 99
TX_NEW By Age/Sex: 50+ Male 2016 121
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 8,869
TX_NEW Pregnancy status 2016 629
TX_NEW Sum of Age/Sex disaggregates 2016 8,869
Cross Cutting Budget Categories and Known Amounts Total: $3,763,998
Human Resources for Health $3,548,088
Construction $200,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Food and Nutrition: Policy, Tools, and Service Delivery $15,910